Ameriprise’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Ameriprise’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-117,148	Closed	-$2.45M	–	4031
2016 Q3	$2.45M	Buy	+117,148	New	+$1.35M	﹤0.01%	2458

Ameriprise's VTAE Position: Q4 2016 in Review

Ameriprise sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 117,148 shares — an estimated $2.45M sold.

Ameriprise first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $2.45M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Ameriprise reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Ameriprise sold 117,148 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $2.45M.
Ameriprise first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Ameriprise's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $2.45M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Ameriprise's 13F filing for Q4 2016, filed 3 Feb 2017.